Navigation Links
Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
Date:2/6/2013

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP therapy, announced today that Jun Ma , Ph.D., Chief Executive Officer and President, will present at RetailInvestorConferences.com.

DATE:

February 7, 2013

TIME:

12:00 PM EST

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive, online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About Vasomedical, Inc.

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales represent
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon To Present At The BIO CEO & Investor Conference
2. OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
3. Hospira to Present at Upcoming Investor Conferences
4. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
5. Tengion to Present at the BIO CEO & Investor Conference
6. ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12
7. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
8. Regulus to Present at Two Upcoming Investor Conferences
9. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
10. Epizyme to Present at Upcoming Conferences in February
11. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MYERS, Fla. , Jan. 23, 2015  Today the ... of Novartis, Bexsero® for the prevention of serogroup ... 25. Bexsero and Pfizer,s vaccine Trumenba®, which received FDA ... helping prevent this devastating disease. "I ...
(Date:1/23/2015)... to Fight Chronic Disease (PFCD) released a public opinion poll of ... study analyzing the impact of increased cost sharing on patient adherence ... educate policy makers and the public on the costs of chronic ... the Iowa healthcare exchange could be improved ...
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... and Efficacy Data Presented at 1st IASLC-ESMO European Lung ... ... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused,on ... trial of picoplatin confirming previously announced interim,results showing a survival benefit ...
... Replidyne, Inc.,(Nasdaq: RDYN ) announced today that ... clinical trial testing faropenem medoxomil,(faropenem) in patients with ... action to conserve its cash assets and support,initiatives ... programs., The AECB study is one in ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 2Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 3Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit 4Replidyne Discontinues Phase III Trial 2Replidyne Discontinues Phase III Trial 3
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... A new white paper by The ... in the long-term care environment as well as provides ... The paper, “The Power of Person-Centeredness in Long-Term Care: ... of the patient, resident and family experience in long-term ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... eliminate rabies in dogs//., ,The vaccine, in the ... scientists at the High Security Animal Disease Laboratory (HSADL)., ... stray dogs due to its artificial taste enhancers - like ... inside the dog's mouth, the capsule bursts and the medicine ...
... Mount Sinai School of Medicine have just developed an ... microdomains of leukocytes// or white blood cells. Microdomains are ... which receptors and signaling molecules accumulate during cell activation. ... white blood cell subsets and their forming microdomains in ...
... An Indian American fitness guru has created a fusion of ... in the United States//. , ,Sarina Jain, also ... Bhangra' and is credited with the introduction of Bhangra, the ... ,Jain holds her aerobic classes all over the US, ...
... are increasingly at the risk of becoming infected with ... active TB disease//, according to an analysis of previously ... ,About one-third of the world’s population is infected with ... is usually rendered inactive by the immune system, according ...
... A recent report published by the Center for Science in ... served in popular hotels// are very high in calories. The ... increased a lot which is leading to many health issues ... the food and its nutritional information enable the consumer to ...
... Compendium of Health Statistics published by the Office of Health ... method. This is costing the NHS twice as much as ... the deliveries by C section have increased to 23.2%. There ... 1995 to 2006. There is an increase of emergency C ...
Cached Medicine News:Health News:New Imaging Technique Tracks Traffic Patterns of White Blood Cells 2Health News:Susceptibility to TB is High Among the Smokers 2
The convenience of disposable type lenses available in a wide variety of options. Recommended replacement schedule: one week for extended wear, two weeks for daily wear....
Acuvue2 is designed to be worn as a two-week daily wear lens (which means you take the lenses out each night). It can also be worn as a one-week extended wear lens (which means you can sleep in them)...
... content spherical soft lens manufactured using ... for use in the correction of ... wear basis. The increased mid-peripheral thickness ... good handling across the power range. ...
... An easy-to-fit low water content spherical soft ... III" or cast molding technology, and designed ... and hyperopia on a daily wear or ... provides good oxygen transmission, while an increased ...
Medicine Products: